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We describe a system for direct selection of anti-
bodies that are receptor agonists. Combinatorial anti-
body libraries in lentiviruses are used to infect eukary-
otic cells that contain a fluorescent reporter system
coupled to the receptor for which receptor agonist an-
tibodiesaresought. In thisembodimentof themethod,
very large numbers of candidate antibodies express-
ing lentivirus and eukaryotic reporter cells are pack-
aged together in a format where each is capable of
replication, thereby forgingadirect linkbetweengeno-
type and phenotype. Following infection, cells that
fluoresce are sorted and the integrated genes encod-
ing theagonist antibodies recovered.Wevalidated the
system by illustrating its ability to generate rapidly
potent antibody agonists that are complete thrombo-
poietin phenocopies. The systemshouldbegeneraliz-
able to any pathway where its activation can be linked
to production of a selectable phenotype.
INTRODUCTION
The power of combinatorial antibody libraries derives from the
fact that a vast number of antibody genes are rendered infec-
tious, thereby giving them replicative life outside the body (Bar-
bas et al., 1991; Huse et al., 1989; Lerner, 2006; McCafferty
et al., 1990; Orlandi et al., 1989; Sastry et al., 1989). This allows
for the linkage of genotype and phenotype so that interesting an-
tibodies can be selected and propagated. The most commonly
used formats are phage or yeast display systems, where the anti-
body is expressed on the surface of the virus particle or cell, and
the gene encoding it is inside. Nowadays, one of the major goals
of immunochemistry is to use such systems for selection of an-
tibodies that perturb cellular functions. However, because
most of the important antibody targets derive from animal cells,
there is no direct linkage between the phage or yeast selection
systems and the cellular phenotype. Thus, usually antibodies
are selected simply for binding to a target protein, and only
secondarily for function.
We reasoned that if the paradigm of endowing vast arrays of
antibody genes with infectious potential in phage were extended734 Chemistry & Biology 20, 734–741, May 23, 2013 ª2013 Elsevierto mammalian cells, one could select directly for phenotypes
without the need for intervening steps. The key to the approach
was the construction of a library in a vehicle that is infectious for
animal cells, using a format where the antibody genes are inte-
grated into the genome and can be recovered from selected
cells, thereby linking genotype to phenotype. This is similar in
concept to phage systems in that the genotype and phenotype
are copackaged, except that here, the phenotype is a property
of the host cell and the genotype is the integrated antibody
gene. In earlier experiments, we tested this concept by con-
structing a combinatorial antibody library in lentiviruses (Zhang
et al., 2012). After infection of stable reporter cells, antibodies
could be selected that were full erythropoietin (EPO) agonists.
The system had sufficient power to yield agonists that utilized
the asymmetric mechanism of authentic EPO via generation
and selection of bispecific heterodimeric antibodies. These anti-
body agonists were formed by recombination of the degenerate
antibody protein subunits in cells that had integrated more than
one antibody-encoding gene into their genome. In this case, se-
lection was based on the growth of cells that required EPO for
replication.
Although the generation of antibodies that were functional
mimics of EPO suggested that combinatorial antibody libraries
that were infectious for mammalian cells might be a powerful
approach for selection of diverse agonists, there was a need to
construct a more general system wherein one selects directly
for activation of cellular pathways, rather than cellular replica-
tion. To test this possibility, we constructed a fluorescent
reporter system that operates at the level of single cells and
validated it by selection of antibodies that are complete throm-
bopoietin (TPO) agonists. The reporter system is based on acti-
vation of signaling pathways, and, in a matter of weeks, allows
one to directly select antibody agonists that engage all the down-
stream pathways activated by authentic TPO. Because there is
copackaging of the genes encoding the candidate agonist mol-
ecules with their targets, each cell is a selection system unto
itself.
RESULTS
Construction of a Chimeric TpoR Reporter System
One could study potential antibody agonists using growth of
cells expressing the wild-type TPO receptor (wtTpoR) as the
selectable parameter. However, such a system is not as robust
as one would like because the number of selectable eventsLtd All rights reserved
Figure 1. Construction of the Chimeric Receptor Reporter System
(A) A chimeric receptor composed of the TpoR ectodomain and the IL-6 intracellular signal transduction domain was introduced into HEK293T SIE-BLA cells. The
ectodomain of the chimeric receptor can specifically interact with TPO to generate a signal via the intracellular domain of the IL-6 signal transducer. The box
I-associated JAK1 can phosphorylate the receptor that serves as a docking site for Stats such as Stat3. Receptor-bound Stat that is phosphorylated by JAK1
dimerizes and translocates into the nucleus where it binds to the site-inducible element and activates transcription of the beta-lactamase gene.
(B) The wtTpoR or the two different TpoR-IL6ST chimeric receptors were transduced into HEK293T SIE-BLA cells and stimulated with different concentrations of
TPO. The responses were measured as an OD 460-to-530 nm ratio.
(C) Cells transduced with chimeric receptor 2 were stimulated with recombinant TPO and cells showing the highest response to TPO were sorted into individual
wells. The encircled gated area is shown.
See also Figure S2.
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tential input events from the library. Also, such selections can be
confounded by high backgrounds caused by the appearance of
mutant cells that have sustained cellular proliferation in vitro in
the absence of an agonist. To increase the number of observable
events, we constructed a fluorescent reporter system that al-
lowed screening at the level of single cells. Two reporter cell lines
that were responsive to TPO were constructed starting with
HEK293T cell lines that contain an integrated beta-lactamase
gene under control of the Sis-inducing element (SIE) promoter
sequence. These HEK293T (Sie-bla) cells can be activated by
interleukin-6 (IL-6) via the Jak-Stat signaling pathway. Unfortu-
nately, TPO does not activate the nascent fluorescent reporter
system in these cells even when the wtTpoR is introduced into
them. To overcome this problem, we constructed chimeric re-
ceptors by splicing the TpoR ectodomain to the IL6ST (gp130)
signal-transducing intracellular domain at two different cross-
over points. In one case, the ectodomain of the TpoR from the
N terminus to the box I region (amino acids 1–527) was linked
to the IL6ST signal-transducing intracellular domain from after
the box I region to the C terminus (amino acids 651–918). Alter-
natively, the TpoR ectodomain from the N terminus to before theChemistry & Biology 20,transmembrane helix (amino acids 1–491) was linked to the
IL6ST domain from the transmembrane helix to the C terminus
(amino acids 605–918). When TPO binds to the TpoR ectodo-
main of these chimeric receptors, their intracellular IL-6 signal
transduction component should be engaged, leading to
activation of a pathway that can be detected by generation of
a unique FRET-based fluorescent signal. Indeed, cells contain-
ing these chimeric receptors were now responsive to TPO as
determined by flow cytometry, analysis of the OD460nm-to-
OD530nm ratios in cells (Figures 1A–1C). Cells expressing the
signal could be easily selected with fluorescence-activated cell
sorting (FACS), thereby allowing selective recovery of activated
clones. The first construction gave the strongest fluorescent
enhancement, indicating that the box I element is important
for efficient signal transduction and it was used for further
experiments.
Validation of Single Cell Formats
Because we wished to use a single cell selection format, two
strategies were used to confine the antibodies to the cells that
produced them. In one, the cells were coated with a thin layer
of agar to limit diffusion of antibodies to neighboring cells. In734–741, May 23, 2013 ª2013 Elsevier Ltd All rights reserved 735
Figure 2. Sorting of Activated Cells
Cells expressing the TpoR-IL6ST chimeric receptor were transduced with a naive lentiviral antibody library (left), a lentiviral antibody library that was preselected
for binding to the TpoR (middle), or were stimulated with TPO (right). The FRET substrate was added16 hr after transduction or after addition of TPO, and cells with
the highest OD 460-to-530 nm ratio were sorted (gated area).
See also Figure S3.
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tide lysine-aspartic acid-glutamic acid-leucine was appended
to the C terminus of the antibodymolecule so that it was retained
in the ER lumen.
Antibody candidates in phage were selected initially for their
ability to bind to the purified TpoR by two rounds of panning.
The selected antibodies were characterized with phage ELISA
(Figure S1A available online) followed by nucleic acid sequencing
of a sampling of the positive clones (Figure S1B). Twenty-two se-
quences were recovered. Of these sequences, two different se-
quences were found to be repeated three and nine times,
respectively, indicating a strong enrichment parameter.
To select for antibodies that were agonists, antibody genes
from the entire enriched population of the selected phage were
transferred to lentiviral vectors for infection of reporter cells.
Because the antibody genes are integrated into the genome,
each candidate antibody remains linked to a single reporter
cell. Prior to analysis of the antibody library, the optimal time
for observing induction of the signal after exposure to the
FRET substrate was determined with a kinetic analysis (Fig-
ure S2). The maximum 460 nm emission was observed at
20 hr and disappeared by 48 hr (Figure S2).
Sixteen hours after infection with the antibody library in its
secretory format, the reporter cells were incubated with the
FRET substrate and sorted with flow cytometry (Figure 2). The in-
duction frequency of cells that were infected with antibodies
selected after two rounds of panning against the TpoR was
compared to that of cells infected with a naive unselected library
(Figure 2). Authentic TPO served as a positive control (Figure 2).
As expected, antibodies that were preselected on the TpoR
induced far more cells than those from the unselected library.
Individual fluorescent cells were deposited into microtiter
wells and grown to confluence. The growth media harvested
from these clones was used to test which ones produced active
antibodies as determined both by proliferation of cells containing
the wtTpoR and generation of fluorescence in the reporter cells
containing the chimeric receptor (Figure S3A). There was a
strong positive correlation for the two assays (Figure S3A).736 Chemistry & Biology 20, 734–741, May 23, 2013 ª2013 ElsevierAlthough the cell proliferation assay is not robust for selections,
it is a useful assay once a candidate agonist is obtained. The
antibody genes from the selected cell clones that were produc-
ing active antibodies were recovered with PCR and cloned into
the pFUSE mammalian expression vector for sequencing. The
majority of clones carried a single sequence that, remarkably,
was repeated in many different clones (Figure S3B). As seen
earlier in our studies of the EPO system, some clones had
more than one sequence, consistent with themultiplicity of infec-
tion used (Zhang et al., 2012).
The system would be most useful if active antibodies that are
present in a variety of subcellular compartments could be
selected. To test this hypothesis, one agonist antibody (3D9)
was constructed in both the secretory and ER retention formats
(Figure S4A). The intracellular confinement of antibodies that
carried the retention signal was confirmed by analysis of the
growth medium and cell lysates from cells producing it. The
antibody with an ER retention sequence was present at a high
concentration in the cell lysate, but none was detected in the
growth media. In contrast, a large amount of the antibody that
had a secretory signal was present in the growth media. The
induction of cells was observed for antibodies expressed from
both formats (Figures S4A and S4B). These results indicate
that secretion is not obligatory for receptor activation by anti-
bodies expressed intracellularly, likely because the receptor
has the same overall topology irrespective of whether it is
retained in the ER lumen or anchored in the plasma membrane.
In the secretory pathway, the receptor active site is oriented to
the ER lumen whereas when anchored in the plasma membrane
it faces the extracellular environment, but in both cases, the
signal-transduction domain faces the cytoplasm.
Thrombogenesis by Selected Antibodies
Two of the most active antibodies (3D9 and 14F12) were ex-
pressed in HEK293F cells and were purified using protein-G
affinity chromatography. The half-maximal effective con-
centration (EC50) of the antibodies was determined using
both the cell proliferation and fluorescent reporter assaysLtd All rights reserved
Figure 3. Dose Response of Agonist Anti-
bodies in Both the Fluorescence Reporter
and Cell Proliferation Assays
(A) Reporter cells expressing the TpoR-IL6ST
chimeric receptor were stimulated for 5 hr with
agonist antibodies or TPO over the indicated
concentration range after which the cells were
incubated for 2 hr with the LiveBLAzer-FRET B/G
substrate. Fluorescence emission ratios (460–
530 nm) were plotted against the indicated con-
centrations. HEK293T SIE-BLA cells were used as
a negative control.
(B) TPO-dependent Ba/F3-hMPL cells were stim-
ulated with agonist antibodies or TPO for 72 hr
over the indicated concentration range and cell
proliferation was measured using a MTS assay.
Ba/F3 cells or EPO-dependent TF-1 cells were
used as negative controls. To calculate the EC50,
the data were fitted to a four-parameter logistic
model with GraphPad Prism 6.
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short-term fluorescence assay, the EC50 of antibodies 3D9 and
14F12 are 10 and 500 pM, respectively, compared to the
endogenous protein agonist TPO, which is 20 pM. In contrast,
in the long-term proliferation assay, the EC50 of antibodies 3D9
and 14F12 are 5 and 50 pM, respectively, compared to TPO
which, in this assay, has an EC50 of 70 pM. The differences in
these assays may reflect the superior stability of the antibody
molecule, which can have a half-life of weeks in serum as
compared to20–40hr for authentic TPO (Kuter, 2009). Todeter-
mine if the antibodies andTPOacted at the same site in the TpoR,
we studied whether there was synergy between the different
agonist antibodies and authentic TPO. No synergywas observed
and the activities of the endogenous agonist TPO and the agonist
antibodieswere simply additivewhenbothwere usedat submax-
imal concentrations, indicating that the agonist antibodies and
TPO bind to different mutually exclusive binding sites, or to the
same binding site in the TpoR (Figure S5).
To determine if the antibodies could induce megakaryocyte
formation from human bone marrow stem cells, fresh CD34 pos-
itive cells were treated with the antibodies or TPO and analyzed
by flow cytometry using antibodies against the megakaryocytic
marker CD41 as compared to the leukocyte marker CD45RA
(Figure 4A). Both antibody 3D9 and TPO markedly induced
megakaryocyte formation from human stem cells. These studies
were confirmed by confocal microscopic imaging using different
channels and measurement of the characteristic multinuclear
feature of mature megakaryocytes using nuclear staining and
flow cytometry (Figures 4B and 4C).
The activation of cells by TPO is accompanied by a char-
acteristic pattern of protein phosphorylation in which the Jak2-
Stat3/Stat5, PI3K-Akt, and MAPK pathways are engaged. We
studied the ability of both TPO and the agonist antibodies to acti-
vate these pathways using BAF-3 cells that expressed the wild-
type human TpoR which, unlike unmodified HEK293T (Sie-bla)
cells, can respond to TPO. Importantly, the agonist antibodies
activated all three pathways, as did authentic TPO, indicating
that their mechanisms of action were similar (Figure 5). As inChemistry & Biology 20,other studies, antibody 3D9 had a lower EC50 than antibody
14F12.
As an orthogonal measure of overall mechanistic similarity,
highly specific kinase inhibitors were studied using the cell pro-
liferation assay. If the agonist antibodies and authentic TPO op-
erate on the same pathway, the profile of inhibition should also
be the same. We studied the kinase inhibitors LY294002,
PD98059, and SD-1029, which are specific for the phosphatidy-
linositol 3 (PI3)-, Jak2-, and MEK-1-mediated pathways. The cell
proliferation induced by both the agonist antibodies and
authentic TPO was inhibited in a dose-dependent manner by
the PI3K and JAK2 but not the MEK-1 inhibitors, again indicating
that they activate similar pathways (Figure S6).
Activation of Platelet Formation In Vivo
There is a high degree of sequence similarity between themurine
and human TpoRs (Figure S7A). This relatedness makes study of
the activity of our agonist antibodies in the mouse feasible,
thereby greatly simplifying assessment of their putative thera-
peutic utility. Immunochemical studies showed that antibody
3D9 reacts with both the human and mouse TpoRs (Figure S7B).
Also, both purified mouse and human TpoR ectodomains can
inhibit the activation of the fluorescent reporter cells by the
agonist antibody (Figure S7C). We took advantage of this
cross-reactivity to study the ability of the agonist antibodies to
induce platelet formation in vivo in the mouse. At a single dose
of 540 mg/kg, the agonist antibody 3D9 increased the platelet
count 3-fold by 8 days (Figure 6) This degree of induction is bet-
ter than the thrombogenesis seen with rhTPO in mice even
though it was administered twice per day for 5 consecutive
days (Frederickson et al., 2006).
DISCUSSION
The main purpose of the present experiments was to develop a
screening format that could unleash the discovery potential of
combinatorial antibody libraries that are infectious for eukaryotic
cells. The central idea is that genotype and phenotype are linked734–741, May 23, 2013 ª2013 Elsevier Ltd All rights reserved 737
Figure 4. Ability of Agonist Antibodies or TPO to Induce Differentiation of Megakaryocyte Lineage Cells
Hematopoietic stem cells were treated with different concentrations of TPO or agonist antibodies for 14 days.
(A) The cells were stained with a phycoerythrin-conjugated antihuman CD41 antibody and APC conjugated antihuman CD45RA antibody and analyzed by flow
cytometry. The CD41+CD45RA cell populations were gated for further analysis.
(B) The cell nuclei were stained with Hoechst dye and the DNA content was analyzed with flow cytometry.
(C) The cells were stained with phycoerythrin-conjugated antihuman CD41 antibody, APC-conjugated antihuman CD45RA antibody, FITC-conjugatedWGA, and
Hoechst dye, and were analyzed with confocal microscopy. Two mature megakaryocytes are shown.
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agonist activity. A system that reports at the level of single cells
is necessary if one wishes to take full advantage of the vast num-
ber of different antibodies in modern combinatorial libraries,
because one needs to match the size and diversity of the library
with an at least equal number of reporting elements that function
individually. As illustrated here, cells where the cytokine path-
ways are activated via JAK/STAT signaling can be easily
selected with FACS and the antibody gene(s) recovered. One
can also envision selection of other important antibodies such
as those that modulate GPCR pathways where one can study,
for example, b-arrestin-based systems by using the same
FRET substrate used here (Zhang and Xie, 2012; Zlokarnik
et al., 1998). Although such agonists to GPCR type receptors
may be rare, they can be found because the coupling of the
vast diversity of modern combinatorial antibody libraries to an in-
fectious format for eukaryotic cells allows for a very large number
of single cell trials at the rate of about two million per hour. While
discovery systems based on pathway activation are in use for
small molecules, the system reported here differs in that it can
simultaneously interrogate many more potential agonists among
the antibodies in the infecting lentiviruses because the library
size is very large and can be interrogated using single cell for-
mats. Another important difference is that candidate agonists
replicate, thereby allowing the selected molecules to be identi-
fied and produced in quantity without any need for initial
addressability.
Once a reporter system is available, functional agonist-type
antibodies can be obtained in a matter of weeks. Finally,
because we use a genetics-basedmethod, large numbers of po-738 Chemistry & Biology 20, 734–741, May 23, 2013 ª2013 Elseviertential agonists are produced in the very small volume element of
a single cell or its compartments so that their molar concentra-
tions at the receptor expressed by the same cell are very high.
Indeed, in other studies to be reported later, we have used this
method to generate rapidly agonist antibodies to other cytokine
receptors, integrins, and ion channels, as well as those that regu-
late morphogenesis and inhibit viral replication. In some of these
cases, preselection against known targets was used, whereas in
others the selection was blind. These studies also showed that
the method is not confined to secreted antibodies that only act
at the external face of the plasma membrane, thereby general-
izing it to any molecule that coexists with an antibody in a variety
of subcellular compartments. Current immunochemical method-
ology allows construction of antibodies that are secreted,
anchored to the plasma membrane, directed to the ER lumen,
or are present in the cytoplasm. Arguably, the ability of the
combinatorial antibody library to be used for selection against
intracellular antigens may be the most important advance that
this format provides.
While the main purpose of our experiments was to generate a
screening system for agonist antibodies that was able to take full
advantage of the large diversity of antibody libraries, the recov-
ered TPO phenocopies are interesting. They differ from our
previously selected EPO agonist antibodies in that they are ho-
modimers instead of bispecific heterodimers. This may indicate
that the asymmetric binding of the ligand to the EPO receptor
that is obligatory for generation of full agonist efficiency is less
important for activation of the TpoR. Because we used an artifi-
cial chimeric receptor, one might have expected that not all the
pathways that are engaged when the endogenous, wild-typeLtd All rights reserved
Figure 5. Signal Transduction by Agonist Antibodies
JAK2 was purified from cell lysates using affinity to anti-JAK2 agarose and
its phosphorylation was detected with western blotting using anti-
phosphotyrosine antibodies. Phosphorylation of STAT3, STAT5, Akt, and
MAPK induced by agonist antibodies or rhTPO stimulation was detected with
direct western blotting of cell lysates.
See also Figure S6.
Figure 6. In Vivo Activity of the Agonist Antibody 3D9 in the Balb/C
Mouse
Antibody at concentrations of 150 mg/kg, 500 mg/kg, or the PBS vehicle were
injected s.c. once at day 0, and blood was collected every other day for
2 weeks using a Unopette. Platelets were counted with a hemacytometer.
See also Figure S7.
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showed that all of the three known pathways associated with
the TpoR are indeed activated, suggesting that the antibody is
not only a full agonist but also seems to copy the mechanism
initiated by binding of the natural ligand. While others have re-
ported the generation of TpoR agonist antibodies, they were
induced in mice and, thus lack the advantage of cross-reactivity
with the mouse and human TpoR. This cross-reactivity is impor-
tant because it greatly facilitates studies of the properties of opti-
mized antibody variants in vivo. In this respect, it should be noted
that, while already powerful, our agonist antibodies were used as
they came from the selections without any optimization.We have
no doubt that their activity and pharmacokinetics can be
optimized.
SIGNIFICANCE
Combinatorial antibody libraries are in wide use for the
isolation of reagent and therapeutic antibodies. Because
the antibody libraries are usually expressed in phages or
yeasts that do not infect eukaryotic cells, there is no direct
connection between the antibody genotype and the cellular
phenotype. This has now changed with the advent of combi-
natorial antibody libraries that are infectious for animal cells.
When the cell phenotype is coupled to a fluorescent reporter
system, approximately two million antibody events per hour
can be studied. Essentially, this is an autocrine system in
which each cell becomes a selection system unto itself.
Use of this system should allow isolation of important anti-
bodies that perturb the fates of a wide range of cells, such
as cancer and stem cells. Our experience, so far, is that an
antibody peturbant can be selected from any phenotype as
long as a robust assay is available.Chemistry & Biology 20,EXPERIMENTAL PROCEDURES
Cell Lines
The murine IL-3-dependent cell line Ba/F3 (catalog no. ACC 300, DSMZ) was
maintained in RPMI-1640 (Life Technologies) containing 10% (vol/vol) fetal calf
serum (Life Technologies), penicillin, and streptomycin (Life Technologies) and
2 ng/ml rmIL3 (R&D Systems, catalog no. 403-ML-010). The HEK293F cell line
was maintained in Free Style F17 medium with 4 mM GlutaMAX (Life Technol-
ogies). The SIE-BLA HEK293T cell line (Life Technologies, catalog no. K1649)
was maintained in Dulbecco’s modified Eagle’s medium containing 10% (vol/
vol) dialyzed fetal bovine serum, penicillin, streptomycin, nonessential amino
acids, and HEPES (Life Technologies).
Selection of EPOR Binding Antibodies from Combinatorial Antibody
Libraries in Phage
Recombinant purified human TpoR extracellular domain (Ser25-Trp491) (R&D
systems, catalog no. 4444-TR-050) was biotinylated with EZ-Link NHS-PEG4-
Biotin and Biotinylation kits (Thermo Scientific, catalog no. 21455), and the bio-
tinylated protein was used for panning in solution. The combinatorial antibody
scFv library in phage was incubated with the biotinylated TpoR extracellular
domain after which streptavidin-coated DynabeadsM-280 (Life Technologies,
catalog no. 11205) were added to pull down the TpoR-phage complex. Un-
bound phage was removed by washing. Bound phage was eluted with either
TPO (Sino Biological, catalog no. 10381-H08C) or glycine$HCl (pH 2.2). XL1-
blue cells were infected with the eluted phage and grown at 30C overnight.
Bacteria were scraped from the plate and the helper phage VCSM13 was
added to amplify phage for the next round of panning. Twenty-four clones
from each protocol were harvested and their binding to the TpoRwas analyzed
with phage ELISA. The selected phagemids were sequenced with Sanger
sequencing. Sequences were analyzed with Vbase2. The heavy chain
CDR3s were aligned using Clustal W.
Establishment of TPO-Responsive Reporter Cell Lines
Construction of a TpoR-IL6ST Chimeric Receptor
Two chimeric receptors composed of the human TpoR and human IL-6 signal
transducer (IL6ST, GP130) intracellular domain were constructed. In one case,
the ectodomain of TpoR (from the N terminus to the box I region [amino acids
1–527]) was linked to the IL-6 signal transducer intracellular domain (from after
the box I region to the C terminus [amino acids 651–918]). Alternatively, the
TpoR ectodomain (from the N terminus to before the transmembrane helix
(amino acids 1–491]) was linked to the IL6ST domain (from the transmembrane
helix to the C terminus [amino acids 605–918]). The chimeric receptors were734–741, May 23, 2013 ª2013 Elsevier Ltd All rights reserved 739
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drive expression of the receptor.
The CellSensor SIE-bla HEK293T cell line that contains a beta-lactamase re-
porter gene under control of the SIE response element was infected with len-
tiviruses carrying the TpoR-IL6ST chimeric receptor gene. The transduced
cells were stimulated with recombinant TPO and cells showing the greatest
response to TPO (having the highest optical density [OD] 460-to-530 nm ratio)
were sorted into 96-well microtiter plates using a MoFlo XDP Flow Cytometry
Sorter. Single cell clones were allowed to reach confluence, and the response
of single clones to TPOwasmeasured in black-wall, clear-bottom assay plates
using a fluorescence plate reader (Tecan, Infinite M200Pro) using an excitation
filter of 409 nm and emission filters of 460 nm and 530 nm. The clone with the
highest response to TPO was designated as CR2-9.
Establishment of the BaF3/hMpl Cell Line
The human wtTpoR gene was cloned into the lentiviral vector and expressed
under control of the UbC promotor. The murine IL-3-dependent cell Ba/F3
was transduced with lentiviruses carrying the TpoR gene, and TPO-dependent
cells were selected in RPMI 1640 medium containing 20 ng/ml rhTPO (R&D
Systems, catalog no. 288-TP-005).
Construction of the Lentiviral Combinatorial Antibody Library
scFv genes were cut from the phagemid vector and subcloned into the lentivi-
ral vector at the compatible asymmetric SfiI sites as described earlier (Zhang
et al., 2012).
Single Cell Selections Screening of TpoR Agonist Antibodies Using
FACS
Secreted antibody generated during lentivirus preparations was removed
using protein G magnetic beads (New England Biolabs, catalog no.
S1430S). The completeness of the antibody depletion was confirmed with
western blotting with HRP-conjugated anti-human Fc antibody. The TPO-
responsive HEK293T cell CR2-9 was plated at low density 1 day before
transduction. After the cells were transduced with lentiviruses, methylcellu-
lose-based media was placed on top of cell layer prior to overnight culture
to confine the secreted antibodies to the cells that produced them. Before har-
vesting the cells, the methylcellulose-based medium was dissolved using
excess medium and discarded. Cells were detached, and LiveBLAzer FRET
B/G Loading substrate was added (Life Technologies, catalog no. K1095).
Cells with the highest OD 460-to-530 nm ratio were sorted into 96-well micro-
titer plates using a MoFlo XDP Flow Cytometry Sorter. Single cell clones were
allowed to reach confluence, and the conditioned medium harvested from
them was added to 384-well black-wall, clear-bottom microtiter assay plates
containing CR2-9 cells for secondary screening. The conditioned media was
also tested in 384-well microtiter plates containing Ba/F3-hMpl cells. The ef-
fect on cell proliferation was determined using the CellTiter 96 Aqueous nonra-
dioactive cell proliferation assay (Promega, catalog no. G3580). Antibody
genes from the clones giving highest signal were recovered with PCR and
cloned into the pFUSE mammalian expression vector for sequencing, and
the antibody sequences were transfected into HEK293F cells to produce an-
tibodies. Antibodies were purified using HiTrap Protein G HP columns (GE
Healthcare Biosciences, catalog no.17-0405-01) with A¨KTAxpress purifier.
Differentiation of Human CD34+ Hematopoietic Stem Cells
The assays were done in duplicate with hematopoietic stem cells (HSCs) from
two different donors. CD34+ stem cells were isolated from human bone
marrow using a direct immunomagnetic CD34 MicroBead labeling system
(All Cells, catalog no. ABM010). Approximately 50,000 CD34+ HSC cells
were cultured in StemSpan serum-free media (SFEM) (Stemcell Technologies,
catalog no. 09600) supplemented with 50 ng/ml human stem cell factor (SCF)
only or SCF plus different concentrations of human TPO agonist antibodies
3D9 or 14F12 for 14 days. For immunofluorescence assays, cells were fixed
with 3% paraformaldehyde in PBS and blocked for 30 min in 2% BSA in
PBS. The Fc receptor on the cells was blocked for 10 min with purified IgG
from human serum using a concentration of 100 ug/ml (Sigma Life Science,
catalog no. I4506). Cells were stained with PE-conjugated antihuman CD41
(Biolegend, catalog no. 303705) and APC-conjugated antihuman CD45RA
(eBioscience, catalog no. 17-0458-41).740 Chemistry & Biology 20, 734–741, May 23, 2013 ª2013 ElsevierCell nuclei were stained with Hoechst dye, washed with PBS, and analyzed
with a LSRII FlowCytometer (Becton Dickinson). For imaging with confocal mi-
croscopy, in addition to nuclear staining, the cell surface was stained with
WGA Lectin FITC (Genetex, catalog no. GTX 01502). Confocalmicroscopic im-
aging was carried out on cells deposited on slides using a cytospin centrifuge.
Phosphorylation Assays
Ba/F3-hMpl cells were starved in RPMI 1640 medium containing 5% FBS
without TPO for 18 hr. A total of 8 3 106 cells was used for each assay. Cells
were treated at 37C for 20 min with RPMI serum-free medium containing
50 ng/ml TPO, 100 ng/ml agonist antibody 3D9, or 200 ng/ml agonist antibody
14F12. The cells were washed once with ice-cold PBS containing 13Halt pro-
tease and a phosphatase inhibitor mixture (Pierce Chemical, catalog no.
78428) and lysed on ice for 30 min with occasional vortexing in 500 ml immu-
noprecipitation lysis buffer containing 23 Halt protease and the phosphatase
inhibitor mixture. Cell debris was removed by centrifugation at 13,000 3 g for
10min. The phosphorylation status of Stat3, Stat5, Akt, and p44/42MAPKwas
determined with western blot analysis of the cell lysates using anti-phospho-
Stat3 (Tyr705) (D3A7) XP antibody (Cell Signaling Technology, catalog no.
9145P), anti-Phospho-Stat5 (Tyr694) (D47E7) XP antibody (Cell Signaling
Technology, catalog no. 4322P,), anti-phospho-p44/42 MAPK (Erk1/2)
(Thr202/Tyr 204) (197G2) antibody (Cell Signaling Technology, catalog no.
4377S), and anti-phopho-Akt(Thr 308)(244F9) antibody (Cell Signaling
Technology, catalog no. 4056S). The amount of protein in the gel bands was
quantitated using anti-total Stat3 (C-20) (Santa Cruz Biotechnology, catalog
no. sc-482), anti-total Stat5 (C-17) (Santa Cruz Biotechnology, catalog no.
sc-835), anti-Akt (Cell Signaling Technology, catalog no.9272S), and anti-
p44/42 MAPK antibody (Cell Signaling Technology, catalog no. 9102S).
JAK2 was purified from cell lysates by immunoprecipitation for 3 hr at 4C
with anti-JAK2 Agarose (EMD Millipore, catalog no. 16-121). JAK2 was eluted
with low-pH elution buffer (Pierce, catalog no. 88804) and neutralized with 2M
Tris buffer. The immunoprecipitates were analyzed with western blotting using
anti-phospho-JAK2 (Tyr1007/1008) (C80C3) antibody (Cell Signaling Technol-
ogy, catalog no. 3776) and anti-total JAK2 antibody (C-14) (Santa Cruz
Biotechnology, catalog no. sc-34479).
Thrombogenesis in Mice
Normal Balb/C mice, 9 weeks of age, were divided into three groups of six
mice each. All the animal experiments were conducted in accordance with
the Institutional Animal Care and Use Committee guidelines. The groups of
mice were treated s.c. with 150 mg/kg or 500 mg/kg of 3D9 agonist antibody
or PBS as control at day 0. The antibody preparations contained less than
0.0025 EU of endotoxin per microgram of protein as determined by the Chro-
mogenic LAL Endotoxin Assay (Genscript, catalog no. L00350). Each mouse
was anesthetized, and 10 ul of blood was collected from the retro-orbital sinus
using a capillary provided with Unopette Replacement (Medix, catalog no.
BTP-4015) every other day for 14 days (day 0 before injection; days 2, 4, 6,
8, 10, and 13 after treatment). The blood was transferred into an Eppendorf
tube prefilled with 1 ml lysis buffer. The platelets were counted using a
C-Chip INCYTO Disposable hemacytometer (Skc America, catalog no.
DHC-N01) using 403 objective and 103 ocular Zeiss lenses.
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